|
Re: Tamoxifen - 8-10 years?
thanks so much for your reply Tricia
that's my feeling as well - I actually found a SABCS abstract from the 2018 symposium titled "Incidence of late relapse in Her2+ BC patients receiving adjuvant trastuzumab" the conclusion was
"even without extended adjuvant endocrine therapy in both trials, risk of late relapse in HR+ Her2+ BC appeared to be low, particularly in patients with N0/N1 disease. The benefit of extended adjuvant endocrine therapy in this group of patients, particularly those with no lymph node involvement, may not outweigh the SE of continuing therapy beyond 5 years"
cancerres.aacrjournals.org
__________________
diagnosed aug/11
right breast IDC 2.2 cm LVI
neoadjuvant fecx3, tax and her x3
surgery -pCR 0/2 nodes
25 rads
herceptin x18
tamox
prophy bi-msx with TE's oct 15/12
LD flap reconstruction (PM me if you want the details)
zoladex shots monthly until SOFT studies come out
|
Threaded Mode